in the letter to the shareholders. They mentioned meeting with FDA on July 15, 2008. Did they release any news / outcome of that meeting. Thank you

In the US, a pre-IND (“Investigational New Drug”) package has been prepared and presented to the Food and Drug Administration (“FDA”)and a pre-IND meeting is scheduled for July 15, 2008 in Washington, DC to determine what additional laboratory studies or animal trials must take place before human trials can begin."